This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Gregory J. Magarian, MD; Linda M. Lucas, MD; Colleen Colley, PharmD

Arch Intern Med. 1991;151(9):1873-1874.

Abstract
Drug-induced myopathy has been reported with use of lovastatin, nicotinic acid, and clofibrate. A particularly severe form, often accompanied by rhabdomyolysis, has been reported with the use of lovastatin and gemfibrozil; however, as far as we know, no case has been documented with use of gemfibrozil alone. Herein, we report the first case (to our knowledge) of gemfibrozil-induced myopathy, confirmed by drug rechallenge.

(Arch Intern Med. 1991;151:1873-1874)

Author Affiliations
From the Division of General Internal Medicine, Oregon Health Sciences University and Veterans Affairs Medical Center, and the Pharmacy Service, Veterans Affairs Medical Center, Portland, Oregon.

Footnotes
Accepted for publication February 26, 1991.

Reprints not available.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

In Vitro Glucuronidation of Fenofibric Acid by Human UDP-Glucuronosyltransferases and Liver Microsomes
Tojcic et al.
Drug Metab. Dispos. 2009;37:2236-2243.
ABSTRACT | FULL TEXT  

The Toxicology of Ligands for Peroxisome Proliferator-Activated Receptors (PPAR)
Peraza et al.
Toxicol Sci 2006;90:269-295.
ABSTRACT | FULL TEXT  

Rhabdomyolysis and Renal Failure Associated with Gemfibrozil Monotherapy
Layne et al.
The Annals of Pharmacotherapy 2004;38:232-234.
ABSTRACT | FULL TEXT